Citius Oncology CTOR
NASDAQ CTOR
$0.69 +0.02 (+3.37%)
As of: Oct 21, 2026 · 2:06 PM EDT

Citius Oncology (CTOR) Work In Process (2024 - 2026)

Updated

Citius Oncology's Work In Process came in at $6.95 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), unchanged from the prior quarter.

Analysis

Citius Oncology (CTOR) Work In Process (2024 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Citius Oncology's Work In Process was $11.71 million, up 448.7% from FY2024.

  • Going back by fiscal year, Work In Process was $2.13 million in FY2024.
  • The five-year range for quarterly Work In Process is $2.13 million (fiscal Q4 2024) to $11.71 million (fiscal Q4 2025).
  • Business Quant data shows CTOR's Work In Process at $6.95 million (Q2 2026), $6.95 million (Q1 2026) and $11.71 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.19 Bn 1,101.77 Bn 19.71 Bn
2 Johnson & Johnson 616.03 Bn 534.56 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 366.82 Bn 321.20 Bn 12.21 Bn
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 235.89 Bn 191.29 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.32 Bn 115.96 Bn 10.94 Bn
10 Citius Oncology 74.83 Mn 44.42 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.95 Mn
Mar 31, 2026 6.95 Mn
Dec 31, 2025 6.95 Mn
Sep 30, 2025 11.71 Mn
Sep 30, 2024 2.13 Mn
API Access

Citius Oncology Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=CTOR&period=max&api_key=YOUR_API_KEY